Cargando…

Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation

Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Humanized acute GvHD (aGvHD) in vivo models using NOD-SCID il2rγ-/- (NSG) mice are well described and are important tools for investigating pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Hisaki, Luo, Zhi-Juan, Kim, Hye Jin, Newbigging, Susan, Gassas, Adam, Keating, Armand, Egeler, R. Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503770/
https://www.ncbi.nlm.nih.gov/pubmed/26176698
http://dx.doi.org/10.1371/journal.pone.0133216
_version_ 1782381359671541760
author Fujii, Hisaki
Luo, Zhi-Juan
Kim, Hye Jin
Newbigging, Susan
Gassas, Adam
Keating, Armand
Egeler, R. Maarten
author_facet Fujii, Hisaki
Luo, Zhi-Juan
Kim, Hye Jin
Newbigging, Susan
Gassas, Adam
Keating, Armand
Egeler, R. Maarten
author_sort Fujii, Hisaki
collection PubMed
description Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Humanized acute GvHD (aGvHD) in vivo models using NOD-SCID il2rγ-/- (NSG) mice are well described and are important tools for investigating pathogenicity of human cells in vivo. However, there have been only few reported humanized cGvHD mouse models. We evaluated if prolonged inflammation driven by low dose G-CSF-mobilized human PBMCs (G-hPBMCs) would lead to cGvHD following cyclophosphamide (CTX) administration and total body irradiation (TBI) in NSG mice. Engraftment was assessed in peripheral blood (PB) and in specific target organs by either flow cytometry or immunohistochemistry (IHC). Tissue samples were harvested 56 days post transplantation and were evaluated by a pathologist. Some mice were kept for up to 84 days to evaluate the degree of fibrosis. Mice that received CTX at 20mg/kg did not show aGvHD with stable expansion of human CD45(+) CD3(+) T-cells in PB (mean; 5.8 to 23.2%). The pathology and fibrosis scores in the lung and the liver were significantly increased with aggregation of T-cells and hCD68(+) macrophages. There was a correlation between liver pathology score and the percentage of hCD68(+) cells, suggesting the role of macrophage in fibrogenesis in NSG mice. In order to study long-term survival, 6/9 mice who survived more than 56 days showed increased fibrosis in the lung and liver at the endpoint, which suggests the infiltrating hCD68(+) macrophages may be pathogenic. It was shown that the combination of CTX and TBI with a low number of G-hPBMCs (1x10(6)) leads to chronic lung and liver inflammation driven by a high infiltration of human macrophage and mature human T cells from the graft, resulting in fibrosis of lung and liver in NSG mice. In conclusion this model may serve as an important pre-clinical model to further current understanding of the roles of human macrophages in cGvHD.
format Online
Article
Text
id pubmed-4503770
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45037702015-07-17 Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation Fujii, Hisaki Luo, Zhi-Juan Kim, Hye Jin Newbigging, Susan Gassas, Adam Keating, Armand Egeler, R. Maarten PLoS One Research Article Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Humanized acute GvHD (aGvHD) in vivo models using NOD-SCID il2rγ-/- (NSG) mice are well described and are important tools for investigating pathogenicity of human cells in vivo. However, there have been only few reported humanized cGvHD mouse models. We evaluated if prolonged inflammation driven by low dose G-CSF-mobilized human PBMCs (G-hPBMCs) would lead to cGvHD following cyclophosphamide (CTX) administration and total body irradiation (TBI) in NSG mice. Engraftment was assessed in peripheral blood (PB) and in specific target organs by either flow cytometry or immunohistochemistry (IHC). Tissue samples were harvested 56 days post transplantation and were evaluated by a pathologist. Some mice were kept for up to 84 days to evaluate the degree of fibrosis. Mice that received CTX at 20mg/kg did not show aGvHD with stable expansion of human CD45(+) CD3(+) T-cells in PB (mean; 5.8 to 23.2%). The pathology and fibrosis scores in the lung and the liver were significantly increased with aggregation of T-cells and hCD68(+) macrophages. There was a correlation between liver pathology score and the percentage of hCD68(+) cells, suggesting the role of macrophage in fibrogenesis in NSG mice. In order to study long-term survival, 6/9 mice who survived more than 56 days showed increased fibrosis in the lung and liver at the endpoint, which suggests the infiltrating hCD68(+) macrophages may be pathogenic. It was shown that the combination of CTX and TBI with a low number of G-hPBMCs (1x10(6)) leads to chronic lung and liver inflammation driven by a high infiltration of human macrophage and mature human T cells from the graft, resulting in fibrosis of lung and liver in NSG mice. In conclusion this model may serve as an important pre-clinical model to further current understanding of the roles of human macrophages in cGvHD. Public Library of Science 2015-07-15 /pmc/articles/PMC4503770/ /pubmed/26176698 http://dx.doi.org/10.1371/journal.pone.0133216 Text en © 2015 Fujii et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fujii, Hisaki
Luo, Zhi-Juan
Kim, Hye Jin
Newbigging, Susan
Gassas, Adam
Keating, Armand
Egeler, R. Maarten
Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation
title Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation
title_full Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation
title_fullStr Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation
title_full_unstemmed Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation
title_short Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation
title_sort humanized chronic graft-versus-host disease in nod-scid il2rγ-/- (nsg) mice with g-csf-mobilized peripheral blood mononuclear cells following cyclophosphamide and total body irradiation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503770/
https://www.ncbi.nlm.nih.gov/pubmed/26176698
http://dx.doi.org/10.1371/journal.pone.0133216
work_keys_str_mv AT fujiihisaki humanizedchronicgraftversushostdiseaseinnodscidil2rgnsgmicewithgcsfmobilizedperipheralbloodmononuclearcellsfollowingcyclophosphamideandtotalbodyirradiation
AT luozhijuan humanizedchronicgraftversushostdiseaseinnodscidil2rgnsgmicewithgcsfmobilizedperipheralbloodmononuclearcellsfollowingcyclophosphamideandtotalbodyirradiation
AT kimhyejin humanizedchronicgraftversushostdiseaseinnodscidil2rgnsgmicewithgcsfmobilizedperipheralbloodmononuclearcellsfollowingcyclophosphamideandtotalbodyirradiation
AT newbiggingsusan humanizedchronicgraftversushostdiseaseinnodscidil2rgnsgmicewithgcsfmobilizedperipheralbloodmononuclearcellsfollowingcyclophosphamideandtotalbodyirradiation
AT gassasadam humanizedchronicgraftversushostdiseaseinnodscidil2rgnsgmicewithgcsfmobilizedperipheralbloodmononuclearcellsfollowingcyclophosphamideandtotalbodyirradiation
AT keatingarmand humanizedchronicgraftversushostdiseaseinnodscidil2rgnsgmicewithgcsfmobilizedperipheralbloodmononuclearcellsfollowingcyclophosphamideandtotalbodyirradiation
AT egelerrmaarten humanizedchronicgraftversushostdiseaseinnodscidil2rgnsgmicewithgcsfmobilizedperipheralbloodmononuclearcellsfollowingcyclophosphamideandtotalbodyirradiation